Veracyte News - VCYT

Company Name	Stock Ticker Symbol	Market	Type
Veracyte Inc	VCYT	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.51	2.53%	20.63	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
20.12	19.845	20.86	20.63	20.12

more quote information »

Recent News

Date	Time	Source	Heading
5/08/2024	17:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/07/2024	16:10	EDGAR2	Form 8-K - Current report
5/07/2024	16:05	BW	Veracyte Announces First Quarter 2024 Financial Results
5/06/2024	16:05	BW	14 Studies Presented at AUA 2024 Show Decipher Tests’..
4/22/2024	17:00	BW	Veracyte to Release First Quarter 2024 Financial Results on..
4/22/2024	08:30	BW	New Study Shows Veracyte’s Decipher Prostate Test is..
4/16/2024	08:30	BW	Veracyte Announces that Nine Studies Reinforcing the Value..
3/08/2024	16:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/08/2024	16:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/08/2024	16:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/08/2024	16:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/08/2024	16:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/08/2024	16:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/05/2024	17:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/05/2024	17:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/05/2024	17:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/05/2024	17:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/05/2024	17:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/29/2024	17:27	EDGAR2	Form 8-K - Current report
2/29/2024	17:22	EDGAR2	Form 424B7 - Prospectus [Rule 424(b)(7)]
2/29/2024	17:20	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2/29/2024	16:40	EDGAR2	Form S-3ASR - Automatic shelf registration statement of..
2/29/2024	08:06	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/27/2024	17:55	BW	Veracyte’s Decipher Prostate Test Receives Highest..
2/22/2024	16:12	EDGAR2	Form 8-K - Current report
2/22/2024	16:05	BW	Veracyte Announces Fourth Quarter and Full-Year 2023..
2/21/2024	17:00	BW	Veracyte to Participate in the Raymond James 45th Annual..
2/13/2024	16:15	EDGAR2	Form 8-K - Current report
2/08/2024	08:00	BW	Veracyte to Release Fourth Quarter and Full-Year 2023..
2/06/2024	08:23	EDGAR2	Form 8-K - Current report
2/06/2024	08:15	BW	Veracyte Completes Acquisition of C2i Genomics
1/29/2024	16:01	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/08/2024	08:12	EDGAR2	Form 8-K - Current report
1/08/2024	08:00	BW	Veracyte Announces Preliminary Full-Year 2023 Results,..
12/12/2023	16:30	BW	Veracyte to Participate in the 42nd Annual J.P. Morgan..
12/05/2023	16:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/05/2023	16:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/05/2023	16:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/05/2023	16:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/05/2023	16:44	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/01/2023	16:05	BW	Real-World Data Presented at SUO 2023 Show that Veracyte’s..
11/29/2023	08:30	BW	Clinical Validation Data Published in CHEST Demonstrate that..
11/22/2023	08:30	BW	Veracyte Announces Seven Posters Highlighting Clinical Value..
11/08/2023	08:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	16:09	EDGAR2	Form 8-K - Current report
11/07/2023	16:05	BW	Veracyte Announces Third Quarter 2023 Financial Results
11/07/2023	16:00	BW	Veracyte Announces In Vitro Diagnostic Agreement with..
11/02/2023	08:15	BW	Veracyte to Participate in the Stephens Annual Investment..
10/27/2023	08:30	BW	Veracyte Announces SITC 2023 Presentations Offering New..
10/17/2023	08:15	BW	Veracyte to Release Third Quarter 2023 Financial Results on..